David M. Tanen serves as Executive at Nile Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David M. Tanen has executed 11 insider transactions totaling $140.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 14, 2020 involved exercising options for 233,405 shares valued at $0.
David M. Tanen currently holds 365,280 shares of Nile Therapeutics, Inc. (NLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David M. Tanen has been a net buyer of NLTX stock. They have purchased $140.8K and sold $0 worth of shares.
David M. Tanen's most recent insider trade was on Oct 14, 2020, when they sold 233,405 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 14, 2020 | KRON | $599.5K | Conversion | 37,119 | $16.15 | Discretionary |
| Oct 14, 2020 | KRON | $0 | Conversion | 231,553 | $N/A | Discretionary |
| Oct 3, 2016 | ARNI | $0 | Purchase | 142,857 | $N/A | Discretionary |
| Jan 12, 2016 | ARNI | $126.7K | Purchase | 362,015 | $0.35 | Discretionary |
| Dec 16, 2008 | NLTX | $2.9K | Purchase | 2,500 | $1.15 | Discretionary |
| Dec 15, 2008 | NLTX | $2.6K | Purchase | 2,480 | $1.05 | Discretionary |
| Dec 15, 2008 | NLTX | $21 | Purchase | 20 | $1.04 | Discretionary |
| Dec 12, 2008 | NLTX | $5.9K | Purchase | 4,000 | $1.47 | Discretionary |
| Dec 11, 2008 | NLTX | $2.8K | Purchase | 4,000 | $0.69 | Discretionary |